Top Suppliers:I want be here


1147271-25-7

1147271-25-7 structure
1147271-25-7 structure

Name 2-Amino-8-(2-morpholin-4-yl-ethoxy)-4-phenyl-indeno[1,2-d]pyrimidin-5-one
Description JNJ-40255293 is a high-affinity human A 2A receptor antagonist with a KiKi of 7.5 nM. JNJ-40255293 can be used in the research of neurodegenerative diseases such as Parkinson's disease[1].
Related Catalog
In Vivo JNJ-40255293 (0.1-10 mg/kg, p.o.) 可以逆转氟哌啶醇 (HY-14538) 诱导的雄性 Balb/c 小鼠僵直症。在雄性 Wistar 大鼠中,JNJ-40255293 也可以剂量依赖性地逆转氟哌啶醇(0.63 mg/kg,皮下注射)诱导的强直性昏厥,增强主动觉醒,显着逆转利血平(HY-N0480)引起的运动活性缺陷[1]。
References

[1]. John R Atack, et al. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease. ACS Chem Neurosci. 2014 Oct 15;5(10):1005-19.   

Molecular Formula C23H22N4O3
Molecular Weight 402.45
Exact Mass 402.16900
PSA 90.57000
LogP 3.16730
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.